SCHEMBL9248554

SCHEMBL9248554

CCCCCn1[nH]c(=O)[nH]c1=O

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS1 P23219 3/20 0.38
PTGS2 P35354 3/20 0.38
MGLL Q99685 2/20 0.38
FAAH O00519 1/20 0.38
DAO P14920 4/20 0.38
HTT P42858 1/20 0.38
CYP1A2 P05177 3/20 0.37
CYP2C19 P33261 3/20 0.37
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
GAA P10253 1/20 0.37
MAPK10 P53779 1/20 0.37
CYP2C9 P11712 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
TSHR P16473 1/20 0.36
LMNA P02545 1/20 0.35
HPGD P15428 1/20 0.35
MAPK1 P28482 1/20 0.35
ALOX5 P09917 2/20 0.35
MAPT P10636 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19231275 0.98 PTGS1 (0.41) PTGS1PTGS2MGLLFAAHDAO
SCHEMBL20149137 0.98 PTGS1 (0.41) PTGS1PTGS2MGLLFAAHDAO
SCHEMBL18499693 0.98 PTGS1 (0.41) PTGS1PTGS2MGLLFAAHDAO
SCHEMBL10519887 0.94 MEN1 (0.40) DAOMEN1KMT2AGAATSHR
SCHEMBL11291118 0.84 CNOT7 (0.41) DAOCYP1A2CYP2C19MEN1KMT2A
SCHEMBL16325221 0.81 MAPK10 (0.42) PTGS1PTGS2MGLLFAAHDAO
SCHEMBL16324726 0.81 MAPK10 (0.42) PTGS1PTGS2MGLLFAAHDAO
SCHEMBL2048833 0.75 MAPT (0.47) PTGS1PTGS2MGLLFAAHHTT
SCHEMBL7746318 0.74 PTGS1 (0.46) PTGS1PTGS2DAOMEN1KMT2A
SCHEMBL4954143 0.73 HTT (0.49) PTGS1PTGS2MGLLFAAHHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1039283-C Use of Porphyrins FMC CORP (US) 1998-07-29 CN claimed
US-5407808-A Treating tumor with inhibitor of protoporphyrinogen conversion to heme FMC CORPORATION (US) 1995-04-18 US claimed
US-5298502-A Exposure to light in presence of oxidase inhibitor FMC CORPORATION (US) 1994-03-29 US claimed
EP-0447491-B1 PROTOPORPHYRINOGEN INHIBITORS AND THEIR USE IN COMPOSITIONS FOR DETECTING AND TREATING TUMOURS FMC CORP (US) 1993-08-11 EP claimed
US-4767552-A OIL, FUEL ADDITIVES THE LUBRIZOL CORPORATION (US) 1988-08-30 US claimed
EP-3010889-B1 ARYLSULFIDE AND ARYLSULFOXIDE DERIVATIVES AS ACARICIDES AND INSECTICIDES BAYER CROPSCIENCE AG (DE) 2018-10-03 EP disclosed
US-9981928-B2 Aryl sulfide derivatives and aryl sulfoxide derivatives as acaricides and insecticides BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2018-05-29 US disclosed
US-20160130240-A1 ARYL SULFIDE DERIVATIVES AND ARYL SULFOXIDE DERIVATIVES AS ACARICIDES AND INSECTICIDES BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2016-05-12 US disclosed
EP-3010889-A1 ARYL SULFIDE DERIVATIVES AND ARYL SULFOXIDE DERIVATIVES AS ACARICIDES AND INSECTICIDES Bayer CropScience Aktiengesellschaft (DE) 2016-04-27 EP disclosed
WO-2014202505-A1 ARYL SULFIDE DERIVATIVES AND ARYL SULFOXIDE DERIVATIVES AS ACARICIDES AND INSECTICIDES BAYER CROPSCIENCE AG (DE) 2014-12-24 WO disclosed
CN-1039283-C Use of Porphyrins FMC CORP (US) 1998-07-29 CN disclosed
CN-1171552-A Use of porphyrins FMC CORP (US) 1998-01-28 CN disclosed
CN-1057194-A Preparation and use of porphyrins FMC CORP (US) 1991-12-25 CN disclosed
US-4767552-A OIL, FUEL ADDITIVES THE LUBRIZOL CORPORATION (US) 1988-08-30 US disclosed
US-4767552-A OIL, FUEL ADDITIVES THE LUBRIZOL CORPORATION (US) 1988-08-30 US disclosed
EP-0270662-A1 URAZOLES COMPOSITIONS USEFUL AS ADDITIVES FOR FUNCTIONAL FLUIDS The Lubrizol Corporation (US) 1988-06-15 EP disclosed
WO-1987007892-A3 URAZOLES COMPOSITIONS USEFUL AS ADDITIVES FOR FUNCTIONAL FLUIDS LUBRIZOL CORP (US) 1988-04-07 WO disclosed
WO-1987007892-A2 URAZOLES COMPOSITIONS USEFUL AS ADDITIVES FOR FUNCTIONAL FLUIDS THE LUBRIZOL CORPORATION (US) 1987-12-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160130240-A1 ARYL SULFIDE DERIVATIVES AND ARYL SULFOXIDE DERIVATIVES AS ACARICIDES AND INSECTICIDES ARSA, SQOR, AHR PTGS1 2050/4885PTGS2 1893/4885MGLL 548/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.